Poseida Therapeutics, Inc.: auditor change — Poseida Therapeutics dismisses PwC, appoints EY as independent auditor for FY2023

Poseida Therapeutics, Inc.

Audit Committee dismissed PwC on March 27, 2023; PwC's 2022 report included an emphasis-of-matter paragraph on additional financing needs.
No disagreements or reportable events between Poseida and PwC during fiscal years 2022, 2021, and subsequent interim period.
Ernst & Young LLP appointed as new independent registered public accounting firm for fiscal year ending December 31, 2023.
Company had not consulted EY on accounting principles or audit opinions prior to engagement.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Poseida Therapeutics, Inc. dismissed PricewaterhouseCoopers LLP as its auditor.

Action: dismissal
Auditor: PricewaterhouseCoopers LLP
Successor: Ernst & Young LLP

Exact text from the filing

On March 27, 2023, the Audit Committee dismissed PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Poseida Therapeutics, Inc. engaged Ernst & Young LLP as its auditor.

Action: engagement
Auditor: Ernst & Young LLP

Exact text from the filing

On March 27, 2023, after conducting an auditor evaluation and selection process, the Audit Committee approved the appointment of Ernst & Young LLP (“EY”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.

View on SEC.gov

Browse all auditor changes →

Source: SEC EDGAR

accession 0001193125-23-085772

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.